Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056104 · ClinicalTrials.gov registry record · NA
Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 543
- Enrollment target
NCT04056104 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 543 participants.
The verdict
NCT04056104, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate and create a new clinical prediction model for CCHD screening that combines non-invasive measurements of oxygenation and perfusion.
Interventions
- DIAGNOSTIC_TEST SpO2 and PIx Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2021-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056104
The ClinicalTrials.gov registry entry for NCT04056104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 543 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SpO2 and PIx Measurement is the first listed.
NCT04056104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056104 about?
NCT04056104 is a clinical study titled "Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements". The purpose of this research is to evaluate and create a new clinical prediction model for CCHD screening that combines non-invasive measurements of oxygenation and perfusion.
What is the current status of trial NCT04056104?
This trial is currently completed. It is a NA study. The enrollment target is 543 participants. The study started on 2019-10-23. Estimated completion is 2021-12-12.
What interventions are being tested in trial NCT04056104?
The interventions under investigation include: SpO2 and PIx Measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04056104?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.